Table 2 CIN in the EU and annual estimates of the number of women with overtreatment.
| EU | |
|---|---|
| Number of inhabitants (2005) | 375 million |
| Number of cases of CIN1, CIN2 and CIN3 in the EU | 330 000 |
| Number of CIN2 cases in the EU | 82 500 |
| Annual number of overtreated patients with CIN2 in the EU by CIN grade | 66 000 |
| Annual number of overtreated patients with CIN2 in the EU by Q‐Ki‐67 | 57 750 |
| Annual number of overtreated patients with CIN2 in the EU by Q‐Ki‐67 and pRb | 47 025 |
| Improvement because of Q‐Ki‐67 per year | 8 250 |
| Improvement because of Q‐Ki‐67 and pRb per year | 18 975 |
CIN, cervical intraepithelial neoplasia; EU, European Union; pRb, retinoblastoma protein.
Data modified from Baak et al. Cell Oncol 2005;27:277–80.